Qu Zhang
116 Zhuodaoquan South Road
Wuhan, 430079, China
Wuhan, 430079, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tislelizumab With Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Questions on Treatment Tolerance and Follow-Up Duration.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 05, 2026
Association of oxidative balance score with metabolic syndrome and its components in middle-aged and older individuals in the United States.
Journal: Frontiers in nutrition
Published: November 06, 2024
Proton beam therapy for a patient with prostatic rhabdomyosarcoma: a case report and review of the literature.
Journal: Frontiers in oncology
Published: September 19, 2024
TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo.
Journal: Oncology letters
Published: April 22, 2015
STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 08, 2014
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 27, 2014
Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo.
Journal: Cancer biology & therapy
Published: September 13, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026